Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.

Abstract

OBJECTIVE To determine prognostic factors for progression-free survival (PFS) and overall survival (OS) for stage I-II cervical-cancer patients treated using computed-tomography (CT)-planned high-dose-rate (HDR) intracavitary brachytherapy (BT). METHODS A total of 150 patients were treated for Stage I-II cervical cancer using CT-planned BT between 4/2004… (More)
DOI: 10.1016/j.ygyno.2016.09.017

Topics

Cite this paper

@article{Cho2016OutcomesWV, title={Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.}, author={Linda P. Cho and Matthias M Manuel and Paul Catalano and Larissa J. Lee and Antonio L Damato and Robert A. Cormack and Ivan Buzurovic and Mandar S. Bhagwat and Desmond A. O'Farrell and Phillip M. Devlin and A. Viswanathan}, journal={Gynecologic oncology}, year={2016}, volume={143 3}, pages={545-551} }